Navigation Links
EastMed Inc. receives FDA clearance to market uresta(TM) in the U.S.
Date:11/25/2008

NORWELL, MA, Nov. 25 /PRNewswire/ - EastMed Inc., the medical manufacturing company that caters specifically to women's health and wellness, has received FDA clearance to market its flagship product, uresta(TM) Continence Care, in the U.S.

"We are delighted to get the official word from the FDA," said James Lodigiani, CEO and President of EastMed Inc. "Uresta (TM) Continence Care offers an innovative and cost-effective option for the many women who suffer from Stress Urinary Incontinence (SUI)."

Uresta(TM) Continence Care is designed to stop bladder leakage and empower women to manage their SUI with a conservative alternative to traditional products and surgery.

It is estimated that one in three women worldwide have incontinence and more than half of those women have SUI.

"SUI is a widespread, life altering condition and requires a solution that women can easily and comfortably manage," says Dr. Scott Farrell, Founder and VP Medical, EastMed. "Uresta(TM) Continence Care restores self-confidence and allows women to improve their quality of life."

Uresta(TM) Continence Care will be available by prescription in the United States.

EastMed Inc. is dedicated to inventing and bringing to market medical innovations for women's health and wellness. The company was recently awarded the 2008 Medical Design Excellence Award (MDEA) in recognition of its innovative design for women who suffer with SUI. EastMed has also received ISO world class quality certification, standards of quality recognized and respected throughout the world.


'/>"/>
SOURCE Eastmed Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. SuperGen Receives Clearance to Begin Clinical Trials With SGI-1776, a PIM Inhibitor
2. Serica Technologies Receives ISO Certification, Meets International Standards for Medical Device Manufacturing
3. Bavarian Nordic Receives USD 25 Million Milestone Payment After Submission of Important IMVAMUNE(R) Data to The U.S. Health Authorities
4. Cellectricon Receives Milestone Order for Cellaxess(R)HT, the Worlds First High Throughput RNAi Screening System
5. China Medical Technologies Receives SFDA Approval for Breast Cancer HER-2 FISH Probe
6. West Michigans Newest Medical Device Company Receives Support from the West Michigan Science & Technology Initiative and EDF Ventures
7. ProtoKinetix Receives Independent Confirmation of AAGP Anti-Inflammatory Action
8. Valor Medical Closes $1.4 Million Convertible Debt and Receives ISO 13485 Certification
9. Aposense Receives Frost & Sullivan Technology Innovation of the Year Award
10. Solos Endoscopy, Inc. Receives Purchase Order from Connecticut Hospital
11. Caraco Pharmaceutical Laboratories, Ltd. Receives FDA Warning Letter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... February 23, 2017 , ... The Greater Gift Initiative, ... partnership with Compass Research . GGI's mission is to advance global health and ... child in need in honor of each clinical trial volunteer. The vision of GGI ...
(Date:2/22/2017)... , Feb. 22, 2017  Aratana Therapeutics, Inc. (NASDAQ: PETX), ... commercialization of innovative biopharmaceutical products for companion animals, will host ... 8:30 a.m. ET to discuss financial results from the fourth ... Interested participants and investors may access the audio ... ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... the leading medical education provider of women’s health, primary care, and specialty ... Council for Continuing Medical Education (ACCME). ACCME’s Accreditation with Commendation is a ...
(Date:2/22/2017)... Iowa , Feb. 22, 2017 Origin (Origin Agritech, ... biotechnology trait and seed provider, and Arcadia ... company that develops and commercializes agricultural productivity traits and nutritional products, ... key corn biotechnology product developed in China ... global regulatory trials. ...
Breaking Biology Technology:
(Date:2/8/2017)... , Feb. 8, 2017 About Voice ... voice to match it against a stored voiceprint ... as pitch, cadence, and tone are compared to ... minimal hardware installation, as most PCs already have ... different transactions. Voice recognition biometrics are most likely ...
(Date:2/8/2017)... , Feb. 7, 2017 Report Highlights ... The global synthetic-biology ... $11.4 billion by 2021, growing at a compound annual growth ... An overview of the global markets for synthetic biology. - ... for 2016, and projections of compound annual growth rates (CAGRs) ...
(Date:2/8/2017)... 7, 2017 Report Highlights The ... from $8.3 billion in 2016 at a compound annual ... Report Includes - An overview of the global ... with data from 2015 and 2016, and projections of ... of the market on the basis of product type, ...
Breaking Biology News(10 mins):